UBS Group’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148M Sell
840,533
-321,902
-28% -$47.1M 0.02% 859
2026
Q1
$143M Sell
1,162,435
-359,888
-24% -$47.3M 0.02% 791
2025
Q4
$200M Buy
1,522,323
+27,347
+2% +$3.21M 0.03% 576
2025
Q3
$142M Buy
1,494,976
+88,282
+6% +$8.76M 0.02% 784
2025
Q2
$134M Sell
1,406,694
-21,943
-2% -$1.78M 0.02% 764
2025
Q1
$113M Buy
1,428,637
+976,759
+216% +$106M 0.02% 843
2024
Q4
$60.4M Buy
451,878
+123,157
+37% +$17.5M 0.01% 1297
2024
Q3
$42.9M Buy
328,721
+4,066
+1% +$502K 0.01% 1257
2024
Q2
$33.9M Buy
324,655
+1,329
+0.4% +$149K 0.01% 1298
2024
Q1
$43.2M Buy
323,326
+5,557
+2% +$745K 0.01% 1136
2023
Q4
$43M Buy
317,769
+136,885
+76% +$15.8M 0.01% 1069
2023
Q3
$24.2M Sell
180,884
-59,496
-25% -$9.78M 0.01% 1340
2023
Q2
$43.8M Buy
240,380
+73,198
+44% +$14.8M 0.01% 909
2023
Q1
$37.8M Sell
167,182
-54,716
-25% -$11.2M 0.01% 936
2022
Q4
$43.6M Buy
221,898
+80,759
+57% +$16.7M 0.02% 888
2022
Q3
$26.2M Sell
141,139
-55,739
-28% -$11M 0.01% 1093
2022
Q2
$35.3M Sell
196,878
-36,545
-16% -$9.33M 0.01% 946
2022
Q1
$79.3M Sell
233,423
-144,310
-38% -$48.7M 0.03% 609
2021
Q4
$140M Sell
377,733
-38,848
-9% -$14.7M 0.04% 461
2021
Q3
$164M Buy
416,581
+49,353
+13% +$22.7M 0.05% 353
2021
Q2
$169M Buy
367,228
+160,480
+78% +$64.6M 0.05% 342
2021
Q1
$77.2M Sell
206,748
-91,025
-31% -$37.1M 0.03% 616
2020
Q4
$107M Buy
297,773
+1,145
+0.4% +$365K 0.04% 464
2020
Q3
$89.2M Buy
296,628
+17,846
+6% +$6.15M 0.03% 437
2020
Q2
$100M Sell
278,782
-10,227
-4% -$3.29M 0.04% 367
2020
Q1
$76.8M Sell
289,009
-48,932
-14% -$13.7M 0.04% 418
2019
Q4
$109M Buy
337,941
+81,715
+32% +$24.8M 0.04% 429
2019
Q3
$75.8M Buy
256,226
+27,276
+12% +$8.04M 0.03% 502
2019
Q2
$82M Sell
228,950
-36,437
-14% -$11.5M 0.03% 462
2019
Q1
$80.2M Buy
265,387
+55,962
+27% +$16.3M 0.03% 452
2018
Q4
$61.1M Sell
209,425
-68,203
-25% -$21.1M 0.03% 502
2018
Q3
$99.1M Buy
277,628
+90,132
+48% +$28.9M 0.04% 411
2018
Q2
$50.9M Sell
187,496
-8,966
-5% -$2.28M 0.02% 646
2018
Q1
$45.2M Sell
196,462
-4,490
-2% -$1.03M 0.02% 690
2017
Q4
$42.7M Buy
200,952
+46,027
+30% +$9.47M 0.02% 739
2017
Q3
$30M Sell
154,925
-8,586
-5% -$1.6M 0.01% 872
2017
Q2
$27.6M Buy
163,511
+40,478
+33% +$7M 0.01% 860
2017
Q1
$20.4M Sell
123,033
-4,667
-4% -$735K 0.01% 1017
2016
Q4
$15.9M Sell
127,700
-6,159
-5% -$830K 0.01% 1174
2016
Q3
$23.7M Sell
133,859
-29,641
-18% -$4.74M 0.01% 879
2016
Q2
$22.3M Sell
163,500
-657
-0.4% -$93.3K 0.01% 877
2016
Q1
$25.9M Sell
164,157
-55,614
-25% -$8.5M 0.02% 736
2015
Q4
$41M Buy
219,771
+75,229
+52% +$12.1M 0.03% 574
2015
Q3
$24.7M Sell
144,542
-35,192
-20% -$7.11M 0.02% 769
2015
Q2
$38.2M Sell
179,734
-71,046
-28% -$13.9M 0.03% 626
2015
Q1
$45.3M Sell
250,780
-2,563
-1% -$483K 0.03% 546
2014
Q4
$45.5M Buy
+253,343
New +$44.6M 0.03% 576

Other funds holding ILMN

UBS Group's ILMN Position: Q2 2026 in Review

UBS Group reduced its Illumina (ILMN) stake by 28% in Q2 2026, selling an estimated $47.1M and leaving 840,533 shares worth $148M. The position accounts for 0.02% of the portfolio, ranked #859.

UBS Group first reported a position in ILMN in Q4 2014 and has held it in 47 quarters since. The position peaked at $200M in Q4 2025. 937 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • UBS Group held 840,533 shares of Illumina worth $148M as of Q2 2026.
  • UBS Group sold 321,902 Illumina shares in Q2 2026, an estimated $47.1M.
  • Illumina made up 0.02% of UBS Group's portfolio in Q2 2026, its #859 holding.
  • UBS Group first reported a position in Illumina in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Illumina position peaked at $200M in Q4 2025.
  • 937 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.